These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


433 related items for PubMed ID: 26086900

  • 1. Binding specificity of polypeptide substrates in NS2B/NS3pro serine protease of dengue virus type 2: A molecular dynamics Study.
    Yotmanee P, Rungrotmongkol T, Wichapong K, Choi SB, Wahab HA, Kungwan N, Hannongbua S.
    J Mol Graph Model; 2015 Jul; 60():24-33. PubMed ID: 26086900
    [Abstract] [Full Text] [Related]

  • 2. Homology modeling and molecular dynamics simulations of Dengue virus NS2B/NS3 protease: insight into molecular interaction.
    Wichapong K, Pianwanit S, Sippl W, Kokpol S.
    J Mol Recognit; 2010 Jul; 23(3):283-300. PubMed ID: 19693793
    [Abstract] [Full Text] [Related]

  • 3. Structural basis for the activation of flaviviral NS3 proteases from dengue and West Nile virus.
    Erbel P, Schiering N, D'Arcy A, Renatus M, Kroemer M, Lim SP, Yin Z, Keller TH, Vasudevan SG, Hommel U.
    Nat Struct Mol Biol; 2006 Apr; 13(4):372-3. PubMed ID: 16532006
    [Abstract] [Full Text] [Related]

  • 4. Mechanism of NS2B-mediated activation of NS3pro in dengue virus: molecular dynamics simulations and bioassays.
    Zuo Z, Liew OW, Chen G, Chong PC, Lee SH, Chen K, Jiang H, Puah CM, Zhu W.
    J Virol; 2009 Jan; 83(2):1060-70. PubMed ID: 18971276
    [Abstract] [Full Text] [Related]

  • 5. Homology modeling and molecular dynamics study of West Nile virus NS3 protease: a molecular basis for the catalytic activity increased by the NS2B cofactor.
    Zhou H, Singh NJ, Kim KS.
    Proteins; 2006 Nov 15; 65(3):692-701. PubMed ID: 16972281
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Binding mode of the activity-modulating C-terminal segment of NS2B to NS3 in the dengue virus NS2B-NS3 protease.
    de la Cruz L, Chen WN, Graham B, Otting G.
    FEBS J; 2014 Mar 15; 281(6):1517-33. PubMed ID: 24472363
    [Abstract] [Full Text] [Related]

  • 8. Probing the substrate specificity of the dengue virus type 2 NS3 serine protease by using internally quenched fluorescent peptides.
    Niyomrattanakit P, Yahorava S, Mutule I, Mutulis F, Petrovska R, Prusis P, Katzenmeier G, Wikberg JE.
    Biochem J; 2006 Jul 01; 397(1):203-11. PubMed ID: 16489931
    [Abstract] [Full Text] [Related]

  • 9. Binding of low molecular weight inhibitors promotes large conformational changes in the dengue virus NS2B-NS3 protease: fold analysis by pseudocontact shifts.
    de la Cruz L, Nguyen TH, Ozawa K, Shin J, Graham B, Huber T, Otting G.
    J Am Chem Soc; 2011 Nov 30; 133(47):19205-15. PubMed ID: 22007671
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Steady-state cleavage kinetics for dengue virus type 2 ns2b-ns3(pro) serine protease with synthetic peptides.
    Khumthong R, Niyomrattanakit P, Chanprapaph S, Angsuthanasombat C, Panyim S, Katzenmeier G.
    Protein Pept Lett; 2003 Feb 30; 10(1):19-26. PubMed ID: 12625822
    [Abstract] [Full Text] [Related]

  • 12. Identification of a novel inhibitor of dengue virus protease through use of a virtual screening drug discovery Web portal.
    Viswanathan U, Tomlinson SM, Fonner JM, Mock SA, Watowich SJ.
    J Chem Inf Model; 2014 Oct 27; 54(10):2816-25. PubMed ID: 25263519
    [Abstract] [Full Text] [Related]

  • 13. Purified NS2B/NS3 serine protease of dengue virus type 2 exhibits cofactor NS2B dependence for cleavage of substrates with dibasic amino acids in vitro.
    Yusof R, Clum S, Wetzel M, Murthy HM, Padmanabhan R.
    J Biol Chem; 2000 Apr 07; 275(14):9963-9. PubMed ID: 10744671
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Simultaneous uncoupled expression and purification of the Dengue virus NS3 protease and NS2B co-factor domain.
    Shannon AE, Chappell KJ, Stoermer MJ, Chow SY, Kok WM, Fairlie DP, Young PR.
    Protein Expr Purif; 2016 Mar 07; 119():124-9. PubMed ID: 26647367
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Crystal structure of Dengue virus NS3 protease in complex with a Bowman-Birk inhibitor: implications for flaviviral polyprotein processing and drug design.
    Murthy HM, Judge K, DeLucas L, Padmanabhan R.
    J Mol Biol; 2000 Aug 25; 301(4):759-67. PubMed ID: 10966782
    [Abstract] [Full Text] [Related]

  • 19. The active essential CFNS3d protein complex.
    Melino S, Fucito S, Campagna A, Wrubl F, Gamarnik A, Cicero DO, Paci M.
    FEBS J; 2006 Aug 25; 273(16):3650-62. PubMed ID: 16911516
    [Abstract] [Full Text] [Related]

  • 20. Homology model of the dengue 2 virus NS3 protease: putative interactions with both substrate and NS2B cofactor.
    Brinkworth RI, Fairlie DP, Leung D, Young PR.
    J Gen Virol; 1999 May 25; 80 ( Pt 5)():1167-1177. PubMed ID: 10355763
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 22.